KB-R7785, a novel matrix metalloproteinase inhibitor, exerts its antidiabetic effect by inhibiting tumor necrosis factor-α production
(Q73635302)
scientific article published on 01 January 1997
scientific article published on 01 January 1997
Language:
Current Data About
KB-R7785, a novel matrix metalloproteinase inhibitor, exerts its antidiabetic effect by inhibiting tumor necrosis factor-α production
other details
description | scientific article published on 01 January 1997 |
External Links
(P356) |
10.1016/S0024-3205(97)00561-4
|
(P698) |
9275009
|